tiprankstipranks
Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179)
:2179
Hong Kong Market
Want to see HK:2179 full AI Analyst Report?

Compare Jiangsu Recbio Technology Co., Ltd. Class H (2179) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$3.87B
-3.21
-43.03%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.38B
-16.22
142.78%
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$7.99B
9.33
0.45%
1 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$5.34
HK$12.15B
-15.04
126.47%
2 Buy
0 Hold
0 Sell
Moderate Buy
SinoMab Bioscience Ltd.
HK$1.39
HK$1.82B
-7.60
1.54%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.15
-3.91
-43.16%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.37
2.54
138.80%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.43
-0.04
-0.89%
HK:2616
CStone Pharmaceuticals
7.70
4.04
110.38%
HK:3681
SinoMab Bioscience Ltd.
1.32
0.04
3.13%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts